37 research outputs found
The Aftermath of Acute Kidney Injury
This thesis offers insight in the development op acute kidney injury (AKI) en its long-term sequelae
Long-term sequelae of severe acute kidney injury in the critically Ill patient without comorbidity: A retrospective cohort study
Background and Objectives: Acute kidney injury (AKI) necessitating renal replacement therapy (RRT) is associated with high mortality and increased risk for end stage renal disease. However, it is unknown if this applies to patients with a preliminary unremarkable medical history. The purpose of this study was to describe overall and renal survival in critically ill patients with AKI necessitating RRT stratified by the presence of comorbidity. Design, Setting, Participants, and Measurements: A retrospective cohort study was performed, between 1994 and 2010, including all adult critically ill patients with AKI necessitating RRT, stratified by the presence of comorbidity. Logistic regression, survival curve and cox proportional hazards analyses were used to evaluate overall and renal survival. Standardized mortality rate (SMR) analysis was performed to compare long-term survival to the predicted survival in the Dutch population. Results: Of the 1067 patients included only 96(9.0%) had no comorbidity. Hospital mortality was 56.6% versus 43.8% in patients with and without comorbidity, respectively. In those who survived hospitalization 10-year survival was 45.0% and 86.0%, respectively. Adjusted for age, sex and year of treatment, absence of comorbidity was not associated with hospital mortality (OR=0.74, 95%-CI=0.47-1.15), while absence of comorbidity was associated with better long-term survival (adjusted HR=0.28, 95%-CI = 0.14-0.58). Compared to the Dutch population, patients without comorbidity had a similar mortality risk (SMR=1.6, 95%-CI=0.7-3.2), while this was increased in patients with comorbidity (SMR=4.8, 95%-CI=4.1-5.5). Regarding chronic dialysis dependency, 10-year renal survival rates were 76.0% and 92.9% in patients with and without comorbidity, respectively. Absence of comorbidity was associated with better renal survival (adjusted HR=0.24, 95%-CI=0.07-0.76). Conclusions: While hospital mortality remains excessively high, the absence of comorbidity in critically ill patients with RRT-requiring AKI is associated with a relative good long-term prognosis in those who survive hospitalization
Time of injury affects urinary biomarker predictive values for acute kidney injury in critically ill, non-septic patients
Background: The predictive value of acute kidney injury (AKI) urinary biomarkers may depend on the time interval following tubular injury, thereby explaining in part the heterogeneous performance of these markers that has been reported in the literature. We studied the inf
The aftermath of acute kidney injury: a narrative review of long-term mortality and renal function
Acute kidney injury (AKI) is a frequent complication of hospitalization and is associated with an increased risk of
chronic kidney disease (CKD), end-stage renal disease (ESRD), and mortality. While AKI is a known risk factor for
short-term adverse outcomes, more recent data suggest that the risk of mortality and renal dysfunction extends far
beyond hospital discharge. However, determining whether this risk applies to all patients who experience an
episode of AKI is difficult. The magnitude of this risk seems highly dependent on the presence of comorbid
conditions, including cardiovascular disease, hypertension, diabetes mellitus, preexisting CKD, and renal recovery.
Furthermore, these comorbidities themselves lead to structural renal damage due to multiple pathophysiological
changes, including glomeruloscleroses and tubulointerstitial fibrosis, which can lead to the loss of residual capacity,
glomerular hyperfiltration, and continued deterioration of renal function. AKI seems to accelerate this deterioration
and increase the risk of death, CDK, and ESRD in most vulnerable patients. Therefore, we strongly advocate
adequate hemodynamic monitoring and follow-up in patients susceptible to renal dysfunction. Additionally, other
potential renal stressors, including nephrotoxic medications and iodine-containing contrast fluids, should be
avoided. Unfortunately, therapeutic interventions are not yet available. Additional research is warranted and should
focus on the prevention of AKI, identification of therapeutic targets, and provision of adequate follow-up to those
who survive an episode of AKI
Monitoring renal hemodynamics and oxygenation by invasive probes: experimental protocol
Renal tissue hypoperfusion and hypoxia are early key elements in the pathophysiology of acute kidney injury of various origins, and may also promote progression from acute injury to chronic kidney disease. Here we describe methods to study control of renal hemodynamics and tissue oxygenation by means of invasive probes in anesthetized rats. Step-by-step protocols are provided for two setups, one for experiments in laboratories for integrative physiology and the other for experiments within small-animal magnetic resonance scanners.This publication is based upon work from the COST Action PARENCHIMA, a community-driven network funded by the European Cooperation in Science and Technology (COST) program of the European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This experimental protocol chapter is complemented by a separate chapter describing the basic concepts of quantitatively assessing renal perfusion and oxygenation with invasive probes
Selectivity in Methanol Oxidation as Studied on Model Systems Involving Vanadium Oxides
Quantitative assessment of renal perfusion and oxygenation by invasive probes: basic concepts
Renal tissue hypoperfusion and hypoxia are early key elements in the pathophysiology of acute kidney injury of various origins, and may also promote progression from acute injury to chronic kidney disease. Here we describe basic principles of methodology to quantify renal hemodynamics and tissue oxygenation by means of invasive probes in experimental animals. Advantages and disadvantages of the various methods are discussed in the context of the heterogeneity of renal tissue perfusion and oxygenation.This chapter is based upon work from the COST Action PARENCHIMA, a community-driven network funded by the European Cooperation in Science and Technology (COST) program of the European Union, which aims to improve the reproducibility and standardization of renal MRI biomarkers. This introduction chapter is complemented by a separate chapter describing the experimental procedure and data analysis
Degree of impaired kidney function at hospital discharge has a major impact on long-term survival of critically ill patients recovered from renal failure
Univariable and multivariable analysis of characteristics associated with hospital mortality in patients without comorbidity.
<p>CRRT: continuous renal replacement therapy; CVVH: continuous venovenous hemofiltration; ICU: intensive care unit; SOFA: sequential organ failure assessment</p><p>*Score available in 50 cases</p><p>Univariable and multivariable analysis of characteristics associated with hospital mortality in patients without comorbidity.</p
Overall and renal survival of patients that survived hospital admission.
<p>Data are given as percentage of cumulative overall survival and renal survival at 1, 5 and 10 years stratified by the presence of comorbidity.</p><p>Overall and renal survival of patients that survived hospital admission.</p